High-Density Lipoprotein Cholesterol and the Risk of First Ischemic Stroke in a Chinese Hypertensive Population
暂无分享,去创建一个
Xiping Xu | Xiaoshu Cheng | P. Zalloua | Yue Zhang | Xiao Huang | Lishun Liu | Bin-yan Wang | Chengzhang Liu | Gang Li | Chen Chen | Qing Dong | Jingyi Li | Chonglei Bi | Yue Zhang | Chongqian Fang | Hai Ma | Y. Huo | Jingyi Li | Hongxiang Yu | Aimin Li | Chengzhang Liu | Hongxiang Yu | Chen Chen | Chonglei Bi | Chongqian Fang | Hai Ma | Aimin Li | Qing Dong | Lishun Liu | Binyan Wang | Xiao Huang | Xiaoshu Cheng | Pierre Zalloua | Xiping Xu | Yong Huo | Gang Li | Yue Zhang | Jingyi Li | H. Yu | Xiaoshu Cheng | Chen Liu | Hongxiang Yu | Xiao-lei Huang
[1] Jun Lv,et al. Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults , 2019, Nature Medicine.
[2] A. Kengne,et al. Validation of the Friedewald formula for the estimation of low density lipoprotein cholesterol in a sub-Saharan African population. , 2017, Clinical biochemistry.
[3] Y. Kokubo,et al. Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study. , 2017, Atherosclerosis.
[4] B. Nordestgaard. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. , 2016, Circulation research.
[5] Anette Varbo,et al. Triglycerides and cardiovascular disease , 2014, The Lancet.
[6] Sarah Parish,et al. Effects of extended-release niacin with laropiprant in high-risk patients. , 2014, The New England journal of medicine.
[7] J. Willey,et al. Cholesterol level and stroke: a complex relationship. , 2013, JAMA internal medicine.
[8] Jiang He,et al. Serum Lipids and Lipoproteins in Chinese Men and Women , 2012, Circulation.
[9] M. Woodward,et al. Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease: An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific Region , 2011, Circulation.
[10] R. Sacco,et al. Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). , 2009, Archives of neurology.
[11] J. Liao. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. , 2008, Current atherosclerosis reports.
[12] V. Feigin,et al. Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. , 2007, European heart journal.
[13] P. Ridker,et al. Lipid levels and the risk of ischemic stroke in women , 2007, Neurology.
[14] A. Kontush,et al. Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[15] K. Miura,et al. High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study , 2003, Stroke.
[16] L. Chambless,et al. Plasma Lipid Profile and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study , 2003, Stroke.
[17] C. Ballantyne,et al. Influence of Low High-Density Lipoprotein Cholesterol and Elevated Triglyceride on Coronary Heart Disease Events and Response to Simvastatin Therapy in 4S , 2001, Circulation.
[18] S. Ebrahim,et al. HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. , 2000, Stroke.
[19] J. Gamble,et al. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[20] T. Fujinami,et al. HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2. , 1997, Clinical biochemistry.
[21] J. Hokanson,et al. Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.
[22] Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S) , 1995, The Lancet.
[23] A. Tall. An overview of reverse cholesterol transport. , 1994, European heart journal.
[24] Vesa Manninen,et al. Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment , 1992, Circulation.
[25] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.
[26] A. Gotto,et al. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins. , 1990, The American journal of cardiology.
[27] P. P. Toth. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy , 2012 .
[28] G. Moneta,et al. Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .
[29] J. Provencio. High-Dose Atorvastatin after Stroke or Transient Ischemic Attack , 2007 .